External integration in medical technology development: a theoretical perspective

1999 ◽  
Vol 1 (1/2) ◽  
pp. 13
Author(s):  
Paula E. Bobrowski ◽  
Arun Ranchod
Keyword(s):  
Medical Technology ◽  
Technology Development ◽  
Theoretical Perspective

Medical Technology Development in the 1990s

1995 ◽  
Vol 18 (6) ◽  
pp. 1321-1323
Author(s):  
JERRY C. GRIFFIN ◽  
KURT C. WHEELER ◽  
GENA K. SEARS
Keyword(s):  
Medical Technology ◽  
Technology Development

scholarly journals Medical Technology Development and Approval

Circulation ◽  
2004 ◽  
Vol 109 (25) ◽  
pp. 3078-3080 ◽  
Author(s):  
Dean J. Kereiakes ◽  
James T. Willerson
Keyword(s):  
Medical Technology ◽  
Technology Development

scholarly journals Strategic Intellectual Property Management and spin offs during Medical Device Innovation and commercialisation

2021 ◽  
Vol 9 (2) ◽  
pp. 43-51
Author(s):  
Suchita Markan
Keyword(s):  
Intellectual Property ◽  
Medical Device ◽  
Medical Technology ◽  
Technology Development ◽  
Interesting Case ◽  
Ip Protection ◽  
Competitive Edge ◽  
Technology Innovations ◽  
Innovation Space ◽  
Start Ups

Intellectual Property (IP) protection for medical technology innovations is a milestone, generally undermined by Start-ups. Effective and timely IP protection acts as a lifeline for entrepreneurs/start-ups as it not only helps them attract investments and get competitive advantage but also enables marketing tie-ups and potential acquisition by larger companies. This article delineates the strategies for effective IP protection during different phases of technology development to enable medical technology innovators unlock IP potential of their innovations thereby gain competitive edge as well as reap financial rewards. Some interesting case studies and experience sharing by entrepreneurs have also been included for empirical understanding and to serve as practical tools for innovators working in medical device innovation space.

scholarly journals Shaping stem cell therapies in Argentina: regulation, risk management and innovation policies

Sociologias ◽  
2019 ◽  
Vol 21 (50) ◽  
pp. 116-155
Author(s):  
Gabriela Bortz ◽  
Achim Rosemann ◽  
Federico Vasen
Keyword(s):  
Stem Cell ◽  
Technology Development ◽  
Drug Evaluation ◽  
Theoretical Perspective ◽  
Regulatory Framework ◽  
Cell Therapies ◽  
Medicine Regulation ◽  
The Creation ◽  
Experimental Treatments ◽  
Stem Cell Banks

Abstract This paper aims to analyze innovation pathways for stem cell technology in Argentina. Firstly, we present a theoretical perspective on the co-construction of regulation and technology development, positing four main tensions that underlie regulatory building and the shaping of national strategies for regenerative medicine. Regulation is understood as a negotiated process among interests, values, benefits, rewards, and different understandings of safety, efficacy, access and availability. The framework is useful to explore how actors and their visions of desired futures shape the creation of standards and, in turn, how they configure the way these emerging technologies are produced, accessed and used. Secondly, we discuss in detail the Argentine case. We focus on (a) the deployment of state actions on capacity and regulatory building, (b) the creation of new businesses in response to patient expectations, particularly umbilical cord stem cell banks and the supply of experimental treatments, and (c) state-led actions to build a specific regulatory framework (still in the making). Ambiguities and gaps in the current legislation as well as scarce enforcement capabilities configure a legal “grey area” for for-profit experimental treatments. Building a specific regulatory framework is understood to be a part of Science, Technology and Innovation (STI) state agencies’ struggle to govern technology development in terms of national envisaged innovation strategies. Lastly, we show how STI authorities and scientists managed to align a broad coalition of actors that encourage international harmonization strategies, following the pharmaceutical model of drug evaluation based on the multi-phase trial system.

scholarly journals Public Interest in New Medical Discoveries Analyses of US and European Citizens` Interest in and Knowledge of Medical Discoveries and New Science and Technology Issues

2004 ◽  
Vol 19 (1) ◽  
pp. 71-85
Author(s):  
Minah Kang Kim
Keyword(s):  
Medical Technology ◽  
Technology Development ◽  
Science And Technology ◽  
Medical Science ◽  
The United States ◽  
Public Expenditures ◽  
New Science ◽  
Medical Technologies ◽  
Conceptual Structures ◽  
The Us

The rapidly rising cost of health care has been an important policy concern in the United States, and the continuing explosion of medical research and increased utilization of medical technology are believed to be important factors driving up the costs. Several studies have implied that the US's continuous expansion of medical technology development and utilization might derive from Americans' strong commitment to medical innovation and a willingness to pay for expensive medical technologies. Using the data on the US and European citizens' attitudes toward other sciences and technologies and new medical discoveries, this study explores why Americans have such strong devotion to medical technologies. Specifically, this study examines whether the high level of interest that Americans have in new medical discoveries comes from their interest in new inventions or in new scientific discoveries and new science and technology issues show that the conceptual structures and determinants of the American public's interest in medical issues are different from those in science and technology issues. This pattern does not occur among European citizens. The US Government's decisions on public expenditures for medical science compared to those for science and technology issues seem to reflect the public's attitudes toward thses issues.

Sign in / Sign up

Export Citation Format

Share Document